title: Use of warfarin in the patient with cancer.
authors.affiliation: University of Michigan Comprehensive Cancer Center, Ann Arbor, MI 48109, USA. jamaudli@med.umich.edu
authors.forename: Joanna Maudlin
authors.initials: JM
authors.lastname: Pangilinan
authors.forename: Percival H
authors.initials: PH
authors.lastname: Pangilinan
authors.forename: Francis P
authors.initials: FP
authors.lastname: Worden
mesh_terms: D018712:Analgesics, Non-Narcotic / Q000009:adverse effects; D000740:Anemia / Q000139:chemically induced; D000925:Anticoagulants / Q000009:adverse effects / Q000592:standards / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects; D019587:Dietary Supplements; D005260:Female; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D019934:International Normalized Ratio; D008875:Middle Aged; D009369:Neoplasms / Q000097:blood / Q000188:drug therapy; D013921:Thrombocytopenia / Q000139:chemically induced; D014859:Warfarin / Q000009:adverse effects / Q000592:standards / Q000627:therapeutic use*
chemical_list: D018712:Analgesics, Non-Narcotic; D000925:Anticoagulants; D000970:Antineoplastic Agents; D014859:Warfarin